• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Int Immunopharmacol . Vaccination increased host antiviral gene expression and reduced COVID-19 severity during the Omicron variant outbreak in Fuya

tetano

Editor, Senior Moderator
Int Immunopharmacol


. 2023 May 15;120:110333.
doi: 10.1016/j.intimp.2023.110333. Online ahead of print. Vaccination increased host antiviral gene expression and reduced COVID-19 severity during the Omicron variant outbreak in Fuyang City, China

Shasha Li[SUP] 1 [/SUP], Xiaoqiong Duan[SUP] 2 [/SUP], Ning Jiang[SUP] 3 [/SUP], Andre J Jeyarajan[SUP] 4 [/SUP], Charlotte A Warner[SUP] 4 [/SUP], Yujia Li[SUP] 2 [/SUP], Min Xu[SUP] 2 [/SUP], Xiuyong Li[SUP] 1 [/SUP], Lin Tan[SUP] 1 [/SUP], Ming Li[SUP] 1 [/SUP], Tuo Shao[SUP] 4 [/SUP], Shilin Li[SUP] 2 [/SUP], Limin Chen[SUP] 2 [/SUP], Yufeng Gao[SUP] 5 [/SUP], Mingfeng Han[SUP] 6 [/SUP], Wenyu Lin[SUP] 7 [/SUP]



Affiliations
Abstract

Background: The differences in host antiviral gene expression and disease severity between vaccinated and non-vaccinated coronavirus disease 2019 (COVID-19) patients are not well characterized. We sought to compare the clinical characteristics and host antiviral gene expression patterns of vaccinated and non-vaccinated cohorts at the Second People's Hospital of Fuyang City.
Methods: In this case-control study, we retrospectively analyzed 113 vaccinated patients with a COVID-19 Omicron variant infection, 46 non-vaccinated COVID-19 patients, and 24 healthy subjects (no history of COVID-19) recruited from the Second People's Hospital of Fuyang City. Blood samples were collected from each study participant for RNA extraction and PCR. We compared host antiviral gene expression profiles between healthy controls and COVID-19 patients who were either vaccinated or non-vaccinated at the time of infection.
Results: In the vaccinated group, most patients were asymptomatic, with only 42.9 % of patients developing fever. Notably, no patients had extrapulmonary organ damage. In contrast, 21.4 % of patients in the non-vaccinated group developed severe/critical (SC) disease and 78.6 % had mild/moderate (MM) disease, with fever occurring in 74.2 % patients. We found that Omicron infection in COVID-19 vaccinated patients was associated with significantly increased expression of several important host antiviral genes including IL12B, IL13, CXCL11, CXCL9, IFNA2, IFNA1, IFNγ, and TNFα.
Conclusion: Vaccinated patients infected with the Omicron variant were mostly asymptomatic. In contrast, non-vaccinated patients frequently developed SC or MM disease. Older patients with SC COVID-19 also had a higher occurrence of mild liver dysfunction. Omicron infection in COVID-19 vaccinated patients was associated with the activation of key host antiviral genes and thus may play a role in reducing disease severity.

Keywords: COVID-19 vaccination; Disease severity; Immune response genes; SARS-CoV-2.

 
Back
Top Bottom